PresseMitteilungen CategoriesNewBiotechCategory / Pharmaceuticals & Biotech / Biotech Immunovative Inc. Appoints Stella M. Sung, Ph.D. as First Member of Newly Established Medical Advisory Board LOS ANGELES, CA: ... Omni Bio Announces First Results for Its Lead Recombinant Molecule DENVER, CO: Fc-AAT Shown to Be Effective in Mouse Models of Gouty Arthritis ... IBEX Reports Results for the Second Quarter and the Six Months Ended January 31, 2013 MONTREAL, QUEBEC: ... Advanced Proteome Therapeutics Corporation Prepares Proprietary Protein Conjugates to Be Tested for Anti-Cancer Activities VANCOUVER, BRITISH COLUMBIA: ... MethylGene Announces Management Changes MONTREAL, CANADA: ... International Stem Cell Corporation Raises Additional Capital CARLSBAD, CA: ... BioSavita Named Top Life Sciences Company at Largest Business Plan Competition in North America PLYMOUTH, MI: ... Cornerstone Therapeutics Reports Fourth Quarter and Fiscal Year 2012 Financial Results CARY, NC: ... US FDA Grants Orphan-Drug Designation to ProMetic's Plasma-Derived Plasminogen Drug LAVAL, QUEBEC and ROCKVILLE, MARYLAND and TAIPEI, TAIWAN: ... MethylGene Reports Fourth Quarter and Full Year 2012 Financial Results MONTREAL, CANADA: ... Boston Therapeutics Appoints Peter Sheehan, M.D. as Medical Director MANCHESTER, NH: Extensive Clinical Trial Experience in Diabetes and Wound Healing to Bolster Company's Drug Development Programs ... TiGenix Reports Full Year 2012 Financial Results LEUVEN, BELGIUM: ... TiGenix to Obtain National Reimbursement in Spain for Its Innovative Cartilage Therapy ChondroCelect(R) LEUVEN, BELGIUM and MADRID, SPAIN: ... Helix BioPharma Corp. Announces Q2 Fiscal 2013 Results AURORA, ON: ... Titan Pharmaceuticals Schedules Conference Call to Review Fourth Quarter and Full Year 2012 Financial Results SOUTH SAN FRANCISCO, CA: ... Horizon Pharma to Present at the 25th Annual ROTH Conference DEERFIELD, IL: ... Cellceutix Plans for Future Trials Aimed at the Latest Initiatives of 'Breakthrough' Designation by the Food and Drug Administration BEVERLY, MA: Cellceutix Conducts Research on Retinoblastoma Cancer ... Miraculins to License Additional Preeclampsia Technology from Mount Sinai Hospital WINNIPEG, MANITOBA: Unique Form of Key Regulator Protein HIF-1 a Promising Addition to Company's Maternal Health Portfolio ... Sunshine Heart Reports Fourth Quarter and Full Year 2012 Results EDEN PRAIRIE, MN and SYDNEY, AUSTRALIA: ... Prima BioMed to Present at ISBioTech Annual Meeting SYDNEY, AUSTRALIA: ... Page 148 von 247: 1 « .. 147 148 149 150 151 152 153 154 155 156 .. » 247